![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | |
A61K 39/395 | |||
A61P 35/00 |
(11) | Number of the document | 3288980 |
(13) | Kind of document | T |
(96) | European patent application number | 16724512.5 |
Date of filing the European patent application | 2016-04-28 | |
(97) | Date of publication of the European application | 2018-03-07 |
(45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/029878 |
Date | 2016-04-28 |
(87) | Number | WO 2016/176504 |
Date | 2016-11-03 |
(30) | Number | Date | Country code |
201562153954 P | 2015-04-28 | US |
(72) |
YANG, Arvin, US
|
(73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(54) | TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY |
TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY |